Home > Term: hLL1
hLL1
A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. hLL1 is a type of monoclonal antibody. Also called IMMU-110 and milatuzumab.
- Part of Speech: noun
- Industry/Domain: Health care
- Category: Cancer treatment
- Company: U.S. HHS
0
Creator
- Lionel M
-
(Platinum) 5532 points - 100% positive feedback
